Challenges in Developing Robust Genetic Markers and Targets to Predict and Prevent Distant and Peritoneal Recurrence in Gastric Cancer

Gastrointestinal Oncology


  1. 1.
    Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Etoh T, Sasako M, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008;15(10):2934–2942.PubMedCrossRefGoogle Scholar
  2. 2.
    Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8(1):29–39.PubMedCrossRefGoogle Scholar
  3. 3.
    Liakakos T, Roukos DH. More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009; 9(1):1–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. Mediators of vascular remodeling co-opted for sequential steps in lung metastasis. Nature. 2007 Apr 12;446(7137):765–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. for Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol. 2005;2:98–107.PubMedCrossRefGoogle Scholar
  10. 10.
    Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002;9(9):828–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358(15):1636; author reply 1636.PubMedGoogle Scholar
  12. 12.
    Vineis P, Brennan P, Canzian F, Ioannidis JPA, Matullo G, Ritchie M, et al. Expectations and challenges stemming from genome-wide association studies. Mutagenesis. 2008;23:439–44.PubMedCrossRefGoogle Scholar
  13. 13.
    Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Roukos DH. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2008;358:197, author reply 198.PubMedCrossRefGoogle Scholar
  17. 17.
    Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008;118:1590–605.PubMedCrossRefGoogle Scholar
  18. 18.
    Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1.PubMedCrossRefGoogle Scholar
  19. 19.
    Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol. 2008 Aug 23. [Epub ahead of print] DOI: 10.1245/s10434-008-0109-6.

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  1. 1.Biobank Personalized Cancer Biomedicine, Department of Surgery, School of MedicineUniversity of IoanninaIoanninaGreece

Personalised recommendations